Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $116,245,163,450
Number of Records: 1,270
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,497,162,77088
Pfizer$10,948,368,52398
Merck$10,710,400,03189
Teva Pharmaceutical Industries$10,242,576,79696
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,560,456,40484
Takeda Pharmaceutical$3,987,516,44732
Endo International$3,311,990,66730
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentPrimary Offense TypeYearAgencyPenalty Amount sort icon
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2005FDA$36,000,000
Organon USA IncOrganon & Co.price-fixing or anti-competitive practices2004MULTI-AG$36,000,000
Mallinckrodt LLCMallinckrodtControlled Substances Act violation2017DEA$35,000,000
Aegerion Pharmaceuticals Inc.Amryt Pharmadrug or medical equipment safety violation2017DOJ_CIVIL$35,000,000
PfizerPfizeroff-label or unapproved promotion of medical products2014MULTI-AG$35,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2013private lawsuit-federal$35,000,000
Medicis Pharmaceutical Corp.Bausch Healthprice-fixing or anti-competitive practices2018private lawsuit-federal$35,000,000
Momenta Pharmaceuticals Inc.Johnson & Johnsonprice-fixing or anti-competitive practices2020private lawsuit-federal$35,000,000
Novartis Pharmaceuticals CorporationNovartisFalse Claims Act and related2016private lawsuit-federal$35,000,000
UCB Inc.UCBoff-label or unapproved promotion of medical products2011FDA$34,000,000
Celgene CorporationBristol-Myers Squibbprice-fixing or anti-competitive practices2020private lawsuit-federal$34,000,000
Genentech Inc.RocheFalse Claims Act and related2016DOJ_CIVIL$33,500,000
ISTA Pharmaceuticals, Inc.Bausch HealthFalse Claims Act and related2013DOJ_CIVIL$33,500,000
OSI Pharmaceuticals LLCAstellas PharmaFalse Claims Act and related2016DOJ_CIVIL$33,500,000
Watson, Inc.Teva Pharmaceutical IndustriesFalse Claims Act and related2018MS-AG$33,408,547
Alere Inc.Abbott LaboratoriesFalse Claims Act and related2018DOJ_CIVIL$33,200,000
Johnson & JohnsonJohnson & Johnsondrug or medical equipment safety violation2017MULTI-AG$33,000,000
Genzyme CorporationSanofidrug or medical equipment safety violation2015FDA$32,587,439
Abbott LaboratoriesAbbott LaboratoriesFalse Claims Act and related2003MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $32,500,000
OrganonOrganon & Co.off-label or unapproved promotion of medical products2014MULTI-AG$31,000,000
Schering-PloughMerckFalse Claims Act and related2008MO-AG$31,000,000
Sandoz, Inc.Sandoz GroupFalse Claims Act and related2011MS-AG$30,110,618
Mylan N.V.Viatrisinvestor protection violation2019SEC$30,000,000
Wyeth-Ayerst Laboratories DivisionPfizerdrug or medical equipment safety violation2000FDA$30,000,000
Bristol-Myers SquibbBristol-Myers Squibbkickbacks and bribery2016CA-INS$30,000,000
Allergan Inc.AbbVieprice-fixing or anti-competitive practices2022private lawsuit-federal$30,000,000
Glenmark Pharmaceuticals Inc., USAGlenmark Pharmaceuticalsprice-fixing or anti-competitive practices2023DOJ_ANTITRUST$30,000,000
Novartis Pharmaceuticals CorporationNovartisprice-fixing or anti-competitive practices2023private lawsuit-federal$30,000,000
Indivior Inc.Indivior PLCprice-fixing or anti-competitive practices2023private lawsuit-federal$30,000,000
Pharmacia CorporationPfizerFalse Claims Act and related2013WI-AG$29,453,247
Eli Lilly and CompanyEli LillyForeign Corrupt Practices Act2012SEC$29,398,734
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLCTeva Pharmaceutical IndustriesFalse Claims Act and related2011TX-AG$29,230,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $29,000,000
Abbott Laboratories Inc.AbbVieFalse Claims Act and related2008TX-AG$28,000,000
Merck Sharp & Dohme CorpMerckFalse Claims Act and related2010HI-AG$28,000,000
GlaxoSmithKlineGlaxoSmithKlinedrug or medical equipment safety violation2009private lawsuit-federal$28,000,000
MerckMerckdrug or medical equipment safety violation2014private lawsuit-federal$27,700,000
Teva Pharmaceuticals USA Inc. and IVAX LLCTeva Pharmaceutical IndustriesFalse Claims Act and related2014DOJ_CIVIL$27,600,000
Bristol-Myers SquibbBristol-Myers SquibbFalse Claims Act and related2010PA-AG$27,600,000
Forest Laboratories LLCAbbVieprice-fixing or anti-competitive practices2023private lawsuit-federal$27,200,000
Schering-PloughMerckFalse Claims Act and related2004DOJ_CIVIL$27,000,000
Schering-Plough Corp.MerckFalse Claims Act and related2004TX-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000
St. Jude Medical Inc.Abbott Laboratoriesdrug or medical equipment safety violation2021DOJ_CIVIL$27,000,000
AllerganAbbVieoff-label or unapproved promotion of medical products2022CA-SFCA$27,000,000
Teva ParmaceuticalsTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022CA-SFCA$27,000,000
Boehringer Ingelheim Pharma GmbHBoehringer Ingelheimprice-fixing or anti-competitive practices2018private lawsuit-federal$27,000,000
Teva Pharmaceuticals USA Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2018private lawsuit-federal$27,000,000
Watson Pharmaceuticals, Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2011private lawsuit-federal$27,000,000
Pfizer Inc.PfizerForeign Corrupt Practices Act2012SEC$26,339,944
TAP Pharmaceutical Products, Inc.Takeda PharmaceuticalFalse Claims Act and related2001MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440
SanofiSanofiForeign Corrupt Practices Act2018SEC$25,200,000
Eli Lilly and Co.Eli Lillyoff-label or unapproved promotion of medical products2009CT-AG$25,100,000
McNeil-PPC Inc.Johnson & Johnsondrug or medical equipment safety violation2015FDA$25,000,000
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2011FDA$25,000,000
Novartis AGNovartisForeign Corrupt Practices Act2016SEC$25,000,000
Abbott LaboratoriesAbbott Laboratoriesoff-label or unapproved promotion of medical products2018USAO$25,000,000
Johnson & JohnsonJohnson & Johnsonprice-fixing or anti-competitive practices2023private lawsuit-federal$25,000,000
Amgen Inc.AmgenFalse Claims Act and related2013DOJ_CIVIL$24,900,000
AstraZeneca Pharmaceuticals LPAstraZenecaFalse Claims Act and related2003MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000
Amgen Inc.AmgenFalse Claims Act and related2019DOJ_CIVIL$24,750,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516
Biovail Pharmaceuticals Inc.Bausch Healthkickbacks and bribery2009USAO$24,647,876
Apotex Corp.Apotex Corp.price-fixing or anti-competitive practices2020DOJ_ANTITRUST$24,100,000
Merck & Co., Inc.MerckFalse Claims Act and related2011MA-AG$24,000,000
Purdue PharmaPurdue Pharmadrug or medical equipment safety violation2015KY-AG$24,000,000
AbbVie Inc.AbbVieconsumer protection violation2020CA-INS$24,000,000
AstraZenecaAstraZenecaprice-fixing or anti-competitive practices2007private lawsuit-federal$24,000,000
Teva Pharmaceuticals USA Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2015private lawsuit-federal$24,000,000
Pfizer, Inc.PfizerFalse Claims Act and related2018DOJ_CIVIL$23,850,000
Roussel Uclaf S.A.Sanofidrug or medical equipment safety violation2001USAO$23,193,600
Mylan Laboratories Inc.ViatrisFalse Claims Act and related2010TX-AG$23,000,000
Medicis Pharmaceutical Corp.Bausch Healthprice-fixing or anti-competitive practices2018private lawsuit-federal$23,000,000
Valeant Pharmaceuticals International, Inc.Bausch Healthprice-fixing or anti-competitive practices2022private lawsuit-federal$23,000,000
Merck, Sharp & Dohme Corp.Merckconsumer protection violation2014private lawsuit-federal$23,000,000
Abbott LaboratoriesAbbVieprice-fixing or anti-competitive practices2010MULTI-AG$22,500,000
Par Pharmaceutical Companies Inc.Endo Internationaloff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000
Genzyme Corp.SanofiFalse Claims Act and related2013DOJ_CIVIL$22,280,000
Genzyme Corp.SanofiFalse Claims Act and related2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000
Schwarz Pharma Inc.UCBFalse Claims Act and related2010DOJ_CIVIL$22,000,000
Biogen, Inc.BiogenFalse Claims Act and related2020DOJ_CIVIL$22,000,000
Aventis Pharmaceuticals Inc.Sanofiprice-fixing or anti-competitive practices2000private lawsuit-federal$22,000,000
Daiichi PharmaceuticalDaiichi Sankyoprice-fixing or anti-competitive practices2000private lawsuit-federal$22,000,000
Eisai CompanyEisaiprice-fixing or anti-competitive practices2000private lawsuit-federal$22,000,000
Takeda ChemicalTakeda Pharmaceuticalprice-fixing or anti-competitive practices2000private lawsuit-federal$22,000,000
Takeda Chemical Industries Ltd.Takeda Pharmaceuticalprice-fixing or anti-competitive practices2003private lawsuit-federal$22,000,000
Takeda PharmaceuticalsTakeda Pharmaceuticalbenefit plan administrator violation2023private lawsuit-federal$22,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2013private lawsuit-federal$21,500,000
Johnson & JohnsonJohnson & JohnsonForeign Corrupt Practices Act2011DOJ_CRIMINAL$21,400,000
Takeda PharmaceuticalsTakeda PharmaceuticalFalse Claims Act and related2023TX-AG$21,350,000
Schering-Plough CorporationMerckprice-fixing or anti-competitive practices2009CA-AG$21,300,000
Novartis PharmaceuticalsNovartisFalse Claims Act and related2019IL-AG$21,280,356
Pfizer Inc.PfizerFalse Claims Act and related2002MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $21,084,700
Alexion Pharmaceuticals Inc.AstraZenecaForeign Corrupt Practices Act2020SEC$21,000,000
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022RI-AG$21,000,000
Shire Pharmaceuticals LLCTakeda Pharmaceuticaloff-label or unapproved promotion of medical products2014MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,786,034
DUSA Pharmaceuticals, Inc.Sun PharmaceuticalsFalse Claims Act and related2020DOJ_CIVIL$20,750,000
Celgene Corp.Bristol-Myers Squibboff-label or unapproved promotion of medical products2017MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000
GlaxoSmithKline plcGlaxoSmithKlinekickbacks and bribery2016SEC$20,000,000
Jazz Pharmaceuticals Inc.Jazz Pharmaceuticalsoff-label or unapproved promotion of medical products2007USAO$20,000,000
Clovis Oncology Inc.Clovis Oncologyinvestor protection violation2018SEC$20,000,000
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010LA-AG$20,000,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.